Veeva Systems (VEEV) is climbing 7% after delivering stronger-than-expected fourth-quarter results and providing full-year earnings per share guidance that came in above analysts' average estimate.

VEEV develops and markets cloud-based software for life sciences companies.

The Highlights of VEEV's Results and Guidance

The company reported Q4 earnings per share, excluding certain items, of $1.74, well above analysts' average estimate of $1.58. The company's revenue climbed 14% versus the same period a year earlier to $721 million, compared with the mean estimate of $699.4 million.

For the company's full year, it expects adjusted EPS of about $7.32, well above the average estimate of $6.97.  Its revenue guidance was roughly in-line with the mean outlook of $3.06 billion.

VEEV's Comments

CEO Peter Gassner stated that the 20 largest firms in the life sciences sector "seem to be" adopting VEEV's clinical-trial management software as the industry standard.

"Our execution continues to be strong and we see momentum across our product areas, positioning us well to consistently deliver on our goals." CFO Brian Van Wagener said in a statement.

The Recent Price Action of VEEV Stock

In the last month, the shares have dropped 2%, while they are up 12% so far in 2025.

While we acknowledge the potential of VEEV, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than VEEV but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.